CHMA
$3.75
Chiasma
($.06)
(1.57%)
CHMA
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.41)
Revenue:  $0.00 Mil
Thursday
Nov 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CHMA reports earnings?
Beat
Meet
Miss

Where is CHMA's stock price going from here?
Up
Flat
Down
Stock chart of CHMA
Analysts
Summary of analysts' recommendations for CHMA
Score
Grade
Pivots
Resistance
$3.97
$3.89
$3.82

$3.74

Support
$3.67
$3.59
$3.52
Tweet
Growth
Description
Chiasma, Inc. is a biopharmaceutical company. The company's TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.